iRhythm Technologies 

$69.67
20
-$0.31-0.45% 今天

统计数据

当日最高
70.47
当日最低
69.47
52周最高
124.12
52周最低
60.88
成交量
48,082
平均成交量
479,196
市值
2.21B
市盈率
-
股息收益率
-
股息
-

即将到来

收益

31Oct预期
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
下一个
-1.47
-1.12
-0.78
-0.43
预期每股收益
-0.570788
实际每股收益
N/A

人们还关注

此列表基于关注IRTC的Stock Events用户的观察列表。这不是投资建议。

竞争者

这个列表是基于最近市场事件的分析。这不是投资建议。

分析师评级

118.67$平均价格目标
最高估值为 $145。
来自过去6个月内的 9 个评级。这不是投资建议。
买入
100%
持有
0%
卖出
0%

关于

Health Technology
Medical Specialties
Manufacturing
Surgical and Medical Instrument Manufacturing
iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG data. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.
Show more...
首席执行官
Kevin King
员工
2000
国家
US
ISIN
US4500561067

上市公司